| Company Name | Korea Bio-Gen Co., Ltd. | CEO | Tai Woong Boo |
|---|---|---|---|
| Date of Establishment | Mar. 2st. 2001 | Turnover | 19,788 million KRW(2020) |
| Share Outstanding | 8,160,825 (2020.12.31) | Capital | 1,632 million KRW (2020.12.31) |
| Largest Shareholder | Tai Woong Boo | Face Value | 200 KRW |
(Unit : million KRW)
| Financial Items | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Current Assets | 7,096 | 8,622 | 11,607 | 18,208 | 20,780 |
| Non-Current Assets | 7,995 | 8,181 | 8,193 | 9,948 | 10,288 |
| Total Assets | 15,091 | 16,803 | 19,800 | 28,156 | 31,068 |
| Current Liabilities | 7,171 | 4,050 | 7,622 | 1,883 | 2,217 |
| Non-Current Liabilities | 502 | 3,826 | 1,205 | 588 | 688 |
| Total Liabilities | 7,673 | 7,876 | 8,827 | 2,471 | 2,905 |
| Capital | 1,100 | 1,100 | 1,100 | 1,626 | 1,632 |
| Capital Surplus | 46 | 46 | 47 | 15,619 | 15,722 |
| Retained Earnings | 6,272 | 7,781 | 9,826 | 8,440 | 10,809 |
| Total Equities | 7,418 | 8,927 | 10,973 | 25,685 | 28,163 |